News – Page 1125 – Endpoints News

Sleuthy Google upstart Calico forges a rare biotech collaboration on aging with Novartis-backed C4

9 years ago

Pfizer, Merck KGaA score a landmark FDA OK for checkpoint contender avelumab

9 years ago

Report — Sanofi close to bagging Flexion in a looming $1B-plus buyout, shares rocket up

9 years ago

Califf cautions against lowering FDA standards; Editas outlines $1B milestone package

9 years ago

Did President Trump just jump the shark on drug prices?

9 years ago

Ultragenyx shares tumble lower after rare disease drug fails PhII trial

9 years ago

Teva denies big layoffs are planned, but will push greater efficiency and shutter floundering efforts

9 years ago

In preemptive strike, Sanders, Cummings demand PTC chief Peltz spell out his price for controversial Duchenne MD ...

9 years ago

Three considerations for the pharma industry as President Trump focuses on drug pricing

9 years ago

BioClin scores a $30M raise from marquee investors to fuel mid-stage work on a new cancer drug

9 years ago

Neurocrine fleshes out its PhIII case for valbenazine; Avrobio adds to gene therapy pipeline

9 years ago

Staggered by a Duchenne patient’s death, Akashi finally gets a green light to get back into the clinic

9 years ago

After selling a failed Cerulean for scrap value, the executive team wins a bonus reward

9 years ago

Once scored as a potential blockbuster, Novartis’ serelaxin fizzles in critical cardio outcomes test

9 years ago

GAO To Launch Investigation Of FDA’s Orphan Drug Program

9 years ago

After an odyssey of setbacks, FDA finally green-lights Newron’s Parkinson’s drug Xadago

9 years ago

Pierre Fabry forges I/O discovery pact; Actinium surges on CHMP support

9 years ago

Novartis boasts a big new advantage for Cosentyx as data indicate the blockbuster can modify psoriasis

9 years ago

After a rough year in the trenches, Alnylam CEO John Maraganore and his team take a big cut in compensation

9 years ago

Struggling Heat gets a warm response to a snapshot on cancer vax data

9 years ago

What's on biopharma's auction block? EY tracks a growing appetite for pipeline divestment deals

9 years ago

SutroVax raises $64M with plans to challenge Pfizer’s megablockbuster Prevnar 13 for the heavyweight title in ...

9 years ago

Trump blasts Big Pharma again — “somebody’s getting very rich” — and promises drug price legislation

9 years ago

Daré does a reverse merger with an ailing Cerulean; Pulmocide raises $30.4M for RSV therapy

9 years ago

First page Previous page 1122 1123 112411251126 1127 1128 Next page Last page